267 related articles for article (PubMed ID: 15146994)
1. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
Beran J; Douda P; Gniel D; Zent O
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
[TBL] [Abstract][Full Text] [Related]
2. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.
Zent O; Jilg W; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Banzhoff A
Vaccine; 2003 Dec; 21(32):4655-60. PubMed ID: 14585672
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
Wittermann C; Petri E; Zent O
Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
[TBL] [Abstract][Full Text] [Related]
5. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
[TBL] [Abstract][Full Text] [Related]
6. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
[TBL] [Abstract][Full Text] [Related]
7. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
8. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
9. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
[TBL] [Abstract][Full Text] [Related]
11. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
[TBL] [Abstract][Full Text] [Related]
14. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
[TBL] [Abstract][Full Text] [Related]
15. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
Beran J; Xie F; Zent O
Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults.
Zent O; Beran J; Jilg W; Mach T; Banzhoff A
Vaccine; 2003 Jan; 21(7-8):738-41. PubMed ID: 12531352
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events.
von Hedenström M; Heberle U; Theobald K
Vaccine; 1995; 13(8):759-62. PubMed ID: 7483792
[TBL] [Abstract][Full Text] [Related]
18. Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination.
Garner-Spitzer E; Poellabauer EM; Wagner A; Guzek A; Zwazl I; Seidl-Friedrich C; Binder CJ; Stiasny K; Kundi M; Wiedermann U
Front Immunol; 2020; 11():860. PubMed ID: 32528467
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of delayed TBE-vaccine booster.
Askling HH; Vene S; Rombo L; Lindquist L
Vaccine; 2012 Jan; 30(3):499-502. PubMed ID: 22122857
[TBL] [Abstract][Full Text] [Related]
20. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]